Unintentional Death: A Preventable Side-Effect of Chronic Pain Management (22nd Annual National Conference)
This activity consists of a recorded presentation from 22nd Annual National Conference held in Minneapolis, MN on September 24-26, 2013.
Opioid analgesics are the primary culprits in the vast majority of U.S. overdose deaths. An analysis conducted by investigators at the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga., showed that 75.2 percent of pharmaceutical deaths involved opioids, either alone or in combination with other drugs.
“Data recently released by the National Center for Health Statistics show drug overdose deaths increased for the 11th consecutive year in 2010. Pharmaceuticals, especially opioid analgesics, have driven this increase. Other pharmaceuticals are involved in opioid overdose deaths, but their involvement is less well characterized,” according to the CDC. The data show that in 2010 there were 38,329 drug overdose deaths in the United States. Of the pharmaceutical-related overdose deaths, 74.3 percent (16,451) were unintentional, 17.1 percent (3,780) were suicides, and 8.4 percent (1,868) were of undetermined intent. This session will address the gap in chronic pain management that allows for unintentional death.
At the end of this educational activity, participants should be able to
- List the population groups at highest risk for unintentional overdose
- State the purpose behind state prescription drug monitoring programs, as recommended by the CDC
Nabarun Dasgupta, PhD, MP
Scientist, Department of Epidemiology
Gillings School of Global Public Health;
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or their spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.
OptumHealth Education ensures that the content is independent of commercial bias.
|Financial Relationship Key|
G- Grant/Research Support
I-Stocks and Other Ownership Interests
O-Other Financial or Material Support
N-Nothing to disclose
UnitedHealth Group (E) (I)
UnitedHealth Group (E) (I)
Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Participants will receive a certificate upon successful completion of the activity, which includes the following:
- Completing the entire activity
- Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms
You must be logged into your account to participate in this activity. Get started by clicking “Begin” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found under “My Account”, “My Activities.”
Method for Calculating CE Credit
CE credit was calculated by the complexity of content.
This activity is provided by OptumHealth Education.
There was no commercial support received for this activity.
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software prior to the beginning of this activity.
This activity is designed to meet the educational needs of physicians, nurses, case managers, and other healthcare professionals.
- 0.75 AMA
- 0.75 ANCC
- 0.75 Attendance
- 0.75 CCMC - General